Related Experiment Videos
CAG repeat number governs the development rate of pathology in Huntington's disease
J B Penney1, J P Vonsattel, M E MacDonald
1Neurology Service, Massachusetts General Hospital, Harvard Medical School, Boston 02114, USA.
Insights
The number of CAG repeats in Huntington's disease correlates linearly with striatal atrophy relative to age at death. A threshold of 35.5 repeats suggests no pathology is expected, with damage progressing linearly from birth.
Area of Science:
- Neuroscience
- Genetics
- Neuropathology
Background:
- Huntington's disease is a neurodegenerative disorder characterized by progressive motor, cognitive, and psychiatric dysfunction.
- The disease is caused by an expansion of CAG trinucleotide repeats in the huntingtin gene, leading to a polyglutamine tract.
- Neuropathological hallmarks include severe atrophy in the striatum, particularly the caudate nucleus and putamen.
Purpose of the Study:
- To investigate the relationship between CAG repeat length, age at death, and neuropathological severity in Huntington's disease.
- To determine if striatal atrophy in Huntington's disease progresses as a linear function of CAG repeat length and patient age.
Main Methods:
- Analysis of 89 post-mortem Huntington's disease brains.
- Quantification of CAG repeat numbers in the huntingtin gene.
- Assessment of the degree of striatal atrophy.
- Correlation analysis between CAG repeat length, age at death, and striatal atrophy.
Main Results:
- A significant linear correlation was identified between CAG repeat number and the ratio of striatal atrophy to age at death.
- The correlation yielded an intercept of 35.5 CAG repeats, suggesting this as a threshold below which no pathology is expected.
- Striatal damage in Huntington's disease appears to be a linear function of the polyglutamine stretch exceeding 35.5 repeats, multiplied by patient age.
Conclusions:
- Huntington's disease pathology, specifically striatal atrophy, develops linearly from birth, driven by the expanded polyglutamine tract.
- The findings suggest that the pathological process is predictable and potentially targetable.
- Further analysis of striatal function could validate this hypothesis and inform the optimal timing for therapeutic interventions in CAG repeat diseases.
Abstract:
We compared the number of CAG repeats, the age at death, and the severity of neuropathology in 89 Huntington's disease brains. We found a linear correlation between the CAG repeat number and the quotient of the degree of atrophy in the striatum (the brain region most severely affected in Huntington's disease) divided by age at death, with an intercept at 35.5 repeats. The largest CAG repeat length, therefore, at which no pathology is expected to develop is 35.5. These results imply that striatal damage in Huntington's disease is almost entirely a linear function of the length of the polyglutamine stretch beyond 35.5 glutamines multiplied by the age of the patient. Thus, it is predicted that the pathological process develops linearly from birth. Analysis of other measures of striatal function could test this hypothesis and might determine when treatment for CAG repeat diseases should start.